Capsida Biotherapeutics Announces Publication in Nature Neuroscience From Caltech Demonstrating Robust, Non-invasive IV Gene Delivery Targeted to the Brain While Avoiding Liver

THOUSAND OAKS, Calif.: THOUSAND OAKS, Calif., Dec. 9, 2021 /PRNewswire/ -- Capsida Biotherapeutics, Inc., an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies for patients with debilitating and life-threatening genetic disorders, today announced research published in Nature Neuroscience that demonstrated the ability to engineer...

Click to view original post